CNMD

CONMED Corporation Healthcare - Medical Devices Investor Relations →

YES
27.2% BELOW
↓ Approaching Was -26.1% last week
-15% -10% -5% 0% 5% 10% 15%+
Signal Threshold $69.50
14-Week RSI 53
Rel. Volume (14w) This week's trading vs. the 14-week average 0.8x
Buyers vs. Sellers (14w) Are up-weeks or down-weeks getting more volume? 1.08

CONMED Corporation (CNMD) closed at $50.59 as of 2026-11-13, trading 27.2% below its 200-week moving average of $69.50. This places CNMD in the extreme value zone. The stock is currently moving closer to the line, down from -26.1% last week. The 14-week RSI sits at 53, indicating neutral momentum.

Trading volume is running at 0.8x of its 14-week average, which is in the normal range. The balance between buying and selling volume (1.08 ratio) is neutral — neither side is clearly dominating.

Over the past 2003 weeks of data, CNMD has crossed below its 200-week moving average 31 times. On average, these episodes lasted 21 weeks. Historically, investors who bought CNMD at the start of these episodes saw an average one-year return of +26.7%.

With a market cap of $1508 million, CNMD is a small-cap stock. The company generates a free cash flow yield of 7.1%, which is healthy. Return on equity stands at 7.1%. The stock trades at 1.4x book value.

This stock also meets the Yartseva multibagger criteria as a small-cap with strong free cash flow yield and reasonable book value.

Over the past 33.9 years, a hypothetical investment of $100 in CNMD would have grown to $954, compared to $3136 for the S&P 500. CNMD has returned 6.9% annualized vs 10.7% for the index, underperforming the broader market over this period.

Free cash flow has been growing at a 135.3% compound annual rate, with 4 consecutive years of positive cash generation. A business generating more cash every year while trading below its 200-week moving average is exactly the kind of disconnect value investors look for.

Business Health

Annual financials — how the underlying business has performed over the past several years.

Cash Flow Free cash flow & net income ($M)

Revenue Annual revenue ($M) — business growth proxy

Total Debt Balance sheet debt ($M)

ROIC Return on invested capital (%)

FCF Yield Free cash flow / market cap (%) — Yartseva signal

Gross Margin Pricing power & competitive moat (%)

Shares Outstanding Buybacks vs dilution (millions)

Growth of $100: CNMD vs S&P 500

Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.

What Happens After CNMD Crosses Below the Line?

Across 28 historical episodes, buying CNMD when it crossed below its 200-week moving average produced an average return of +20.1% after 12 months (median +18.0%), compared to +12.4% for the S&P 500 over the same periods. 54% of those episodes were profitable after one year. After 24 months, the average return was +37.3% vs +25.3% for the index.

Each line shows $100 invested at the moment CNMD crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.

Bean Score Experimental

The Bean Score measures how far a stock's free cash flow yield has deviated from its own quarterly baseline, normalized by the stock's historical behavior. Between earnings dates, FCF is constant — so the score is purely a function of stock price. The levels below show at what prices CNMD would reach each dislocation threshold.

Current Bean Score +1.01σ
Current FCF Yield 8.80%
Baseline Yield 9.61%
Historical σ 1.69pp

Dislocation Price Levels

Prices where CNMD's Bean Score would hit each σ threshold. Valid until next earnings report: 2027-01-27.

LevelσPriceSignal
Deep Value+2σ$42.50Unusually cheap — analysis point
Value+1σ$50.70Cheap vs. own history
Fair Value+0σ$62.82Historical mean behavior
Expensive-1σ$82.55Expensive vs. own history
Deep Expensive-2σ$120.33Unusually expensive — analysis point

Quarterly FCF & Yield Trailing twelve-month free cash flow and yield at each quarter end

Recent Earnings

DateEPS Est.EPS ActualSurprise
2026-10-28$1.00$1.04+3.7%
2026-07-29$1.11$1.38+24.3%
2026-04-29$0.82$0.89+8.8%
2026-01-28$1.32$1.43+8.0%
Data depth: 2 quarterly baselines, 19 price observations — Limited history (4+ quarters preferred for reliability)

Signal Accuracy Collecting Data

The Bean Score system is accumulating weekly data to validate signal accuracy. After 13+ weeks of history, this section will display win rates and average returns for each σ threshold crossing — answering the question: "When this score says cheap or expensive, does the price subsequently move in the expected direction?"

21 / 13 weeks minimum

the write-ups I read Simply Wall St · Visual company reports and write-ups. Free tier covers five reports a month. referral

Theoretical framework — not backtested or forward-tested. The Bean Score uses trailing twelve-month free cash flow yield as a dislocation identifier. It measures whether the market has pushed a stock's yield unusually far from its own baseline behavior. These levels are analysis points: prices at which the yield deviation becomes unusual enough to justify the work. FCF values update quarterly with earnings; between reports, all movement is price-driven.

Dislocation Scores Experimental

Each score measures deviation from CNMD's own historical baseline — the same idea as the Bean Score, applied to different fundamentals. Positive means cheaper or more dislocated than this stock's norm. Scores marked σ are normalized by the stock's own variability; pp values are simple deltas from its recent baseline.

Yield Dislocation -1.64σ Dividend yield vs own 10-yr norm
Drawdown Score +1.02σ Distance from line vs own history
Sector-Relative +0.42σ Vs sector median this week
Buyback Acceleration -0.3pp YoY share change vs own 3-yr pace (− = accelerating)
Insider Intensity N/A TTM buys / market cap, percentile of buyers
FCF Yield vs History -0.4pp Vs own recent annual mean
Earnings Quality Improving Accrual gap trend (-5.0pp of revenue)

Theoretical framework — not backtested. These scores describe how unusual today's readings are for this specific company. Each one is an analysis point, a reason to open the filings. Annual-statement scores (buyback, accruals, FCF vs history) rest on only ~4 yearly data points and are deltas, not sigmas.

Historical Touches

CNMD has crossed below its 200-week MA 31 times with an average 1-year return of +26.7% after recovery.

Crossed BelowRecoveredWeeksMax Depth1-Year ReturnReturn Since Touch
Aug 1988Jun 19894222.4%+23.8%+3808.5%
Jun 1989Jul 198945.7%+55.0%+4004.0%
Nov 1989Apr 19902429.2%+66.7%+4460.0%
Oct 1992Dec 19921135.2%+31.5%+2148.7%
Mar 1993Sep 19947943.1%-3.3%+1268.0%
Apr 1997Apr 199712.7%+77.5%+557.3%
Nov 1999Nov 199913.9%-37.8%+303.1%
Dec 1999Dec 199911.3%-32.5%+292.3%
Jul 2000Jun 20014945.5%+69.1%+454.8%
Sep 2001Sep 200113.6%+28.0%+286.5%
Jul 2002Jul 200213.2%+12.8%+257.6%
Jan 2003Apr 20031520.3%+42.3%+253.5%
Nov 2005Dec 200515.2%-3.8%+168.5%
Dec 2005Jan 20075823.4%-3.4%+156.9%
Nov 2007Feb 20081216.4%+4.1%+146.4%
Mar 2008May 2008117.1%-45.8%+148.1%
Jun 2008Jul 200813.2%-39.2%+143.0%
Oct 2008Mar 20107353.5%-14.9%+144.3%
Apr 2010Nov 20103127.7%+26.3%+173.4%
Aug 2011Sep 201165.4%+26.6%+177.6%
Jan 2016Feb 201644.8%+19.8%+52.6%
Aug 2016Aug 201643.4%+27.6%+41.7%
Sep 2016Nov 201683.2%+35.2%+42.5%
Feb 2017Mar 201723.8%+49.6%+33.2%
Mar 2020Apr 2020326.4%+164.5%+11.1%
Apr 2020May 202011.3%+119.0%-18.1%
Jun 2020Jun 202010.2%+113.2%-20.4%
Jun 2022Apr 20234226.5%+53.7%-41.2%
Aug 2023Aug 202312.7%-35.3%-50.6%
Sep 2023Nov 20231013.9%-30.7%-51.9%
Jan 2024Ongoing150+55.7%Ongoing-51.6%
Average21—+26.7%—

Frequently Asked Questions

Is CNMD below its 200-week moving average?

Yes. As of 2026-11-13, CONMED Corporation (CNMD) is trading 27.2% below its 200-week moving average of $69.50. The current price is $50.59.

What is CNMD's 200-week moving average price?

CONMED Corporation's 200-week moving average is $69.50 as of 2026-11-13. This is the average weekly closing price over roughly the last 4 years, and it acts as a long-term trend line. When a stock drops below this level, it can signal that the price has fallen far enough from the long-term trend to attract value-oriented investors.

What happens when CNMD drops below its 200-week moving average?

CNMD has crossed below its 200-week moving average 31 times in our data. On average, buying at that moment produced a one-year return of +26.7%. These dips have historically been decent entry points. These episodes lasted 21 weeks on average.

Is CNMD a good value right now?

Here's what our data says about CNMD as of 2026-11-13: The stock is below its 200-week moving average, which is the starting point for our analysis. The 14-week RSI is 53. Free cash flow yield is 7.1%. Return on equity is 7.1%. Price-to-book is 1.4x. This is not a buy or sell recommendation — always do your own research.

How does CNMD compare to the S&P 500?

Over the past 33.9 years, $100 invested in CNMD would have grown to $954, compared to $3136 for the S&P 500. That's 6.9% annualized vs 10.7% for the index. CNMD has underperformed the broader market over this period.

Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.

Data as of week of 2026-11-13